AIP influences the cAMP pathway [32] via inhibitory G proteins (Gαi2) [31], via phosphodiesterases [33, 34] and via interfering with downstream pathway of somatostatin receptors [30], but the exact mechanism how lack of AIP leads to somatotroph adenomas is unclear. The gene discussed is AIP; the disease is growth hormone-secreting pituitary adenoma.